Home > Articles

Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study

Abstract

Aim: In this feasibility study we investigated whether magnetic resonance imaging (MRI) with ultrasmall superparamagnetic iron oxide (USPIO) can be used to identify regional and distant lymph nodes, including mediastinal and celiac lymph node metastases in patients with oesophageal cancer. Patients and methods: Ten patients with a potentially curative resectable cancer of the oesophagus were eligible for this study. All patients included in the study had positive lymph nodes on conventional staging (including endoscopic ultrasound, computed tomography and fluorodeoxyglucose-positron emission tomography). Nine patients underwent MRI+USPIO before surgery. Results were restricted to those patients who had both MRI+USPIO and histological examination. Results were compared with conventional staging and histopathologic findings. Results: One patient was excluded due to expired study time. Five out of 9 patients underwent an exploration; in 1 patient prior to surgery MRI+USPIO diagnosed liver metastases and in 3 patients an oesophageal resection was performed. USPIO uptake in mediastinal lymph nodes was seen in 6 out of 9 patients; in 3 patients non-malignant nodes were not visible. In total, 9 lymph node stations (of 6 patients) were separately analysed; 7 lymph node stations were assessed as positive (N1) on MRI+USPIO compared with 9 by conventional staging. According to histology findings, there was one false-positive and one false-negative result in MRI+USPIO. Also, conventional staging modalities had one false-positive and one false-negative result. MRI+USPIO had surplus value in one patient. Not all lymph node stations could be compared due to unforeseen explorations. No adverse effects occurred after USPIO infusion. Conclusion: MRI+USPIO identified the majority of mediastinal and celiac (suspect) lymph nodes in 9 patients with oesophageal cancer. MRI+USPIO could have an additional value in loco-regional staging; however, more supplementary research is needed.

Author

B.B. Pultrum, E.J. van der Jagt, H.L. van Westreenen, H.M. van Dullemen, P. Kappert, H. Groen, J. Sietsma, M. Oudkerk, J.Th.M. Plukker and G.M. van Dam

Contact Details

Corresponding address:
B. B. Pultrum, MD, Department of Surgery, Division of Surgical Oncology,
University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. Email: b.b.pultrum@chir.umcg.nl

Reference

ICIS Cancer Imaging Volume 9 Issue 1
DOI: 10.1102/1470-7330.2009.0004

Date Posted

6 April 2009

Print PDF